壹連科技(301631.SZ):目前暫無軍工產品相關業務
格隆匯7月4日丨壹連科技(301631.SZ)在互動平臺表示,公司是一家集電連接組件研發、設計、生產、銷售、服務於一體的產品及解決方案提供商。主要產品涵蓋電芯連接組件、動力傳輸組件、低壓信號傳輸組件、柔性線路板等各類電連接組件,可應用於新能源汽車,儲能系統、工業設備、醫療設備、消費電子、低空經濟等多個應用領域,公司目前暫無軍工產品相關業務。公司將持續研發拓展電連接組件應用領域相關技術,同時密切關注行業技術發展動態,積極進行產業領域內技術儲備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.